Table 3.
Conc. e(ng/ml) |
aMatrix factor | %Recovery | |||||||
---|---|---|---|---|---|---|---|---|---|
silmitasertib | bISTD | silmitasertib | bISTD | ||||||
cMean | CV% | cMean | CV% | dMean | CV% | dMean | CV% | ||
Human | 0.6 | 1.06 | 5.7 | 0.97 | 2.1 | 84.2 | 4.2 | 87.6 | 5.3 |
plasma | 100 | 1.06 | 1.9 | 1.00 | 3.0 | 77.4 | 2.0 | 79.4 | 3.0 |
Human | 0.6 | 1.00 | 5.4 | 1.01 | 3.8 | 103.4 | 2.9 | 105.9 | 1.8 |
CSF | 18 | 1.00 | 3.3 | 0.99 | 3.2 | 106.2 | 1.5 | 108.5 | 3.5 |
Mouse brain | 4 | 0.70 | 8.3 | 1.12 | 9.8 | 74.1 | 6.1 | 83.8 | 3.5 |
32 | 0.83 | 3.4 | 1.12 | 1.1 | 67.4 | 2.4 | 95.3 | 4.7 |
Matrix factor (MF) and recovery were evaluated for silmitasertib at two concentration levels for each matrix
ISTD is at the fixed concentration of 6 ng/ml
Mean MF of six lots of human plasma and CSF
Mean recovery from one lot of human plasma and CSF in triplicate
For mouse brain, the concentration unit is ng/g.